News
Prop firms generally allow you to trade using the firm’s capital while minimizing your financial risk. Start your research ...
Ousia Pharma logo Omega Funds Logo . Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplas ...
Pioneering a first-in-class drug-targeting approach that leverages hormone analogues to deliver small-molecule neuroplasticity modulators directly to the brain's appetite control centersFinancing ...
Lawyers, as guardians of justice and the rule of law, represent a significant barrier to those who seek to impose tyranny or ...
The court previously denied the defendant’s CPLR 3211 motion to dismiss the amended complaint. The defendant asserted counterclaims for breach of contract against the co-op and alleged “breach of ...
No one in politics today has lived through a first 100 days like the one Donald ... thing to me has been Trump’s targeting of large law firms with executive orders, which then led to a bunch ...
“We executed a complex restructuring to acquire the Pelthos assets, incubated the technology that became ZELSUVMI, achieved FDA approval for this first-in-class medication ... across global markets.
About JEGI CLARITYJEGI CLARITY is a pre-eminent M&A advisory firm for the media, events, marketing, information and ...
At the company's recent Direct Connect conference, however, the new CEO made it clear that not only does Intel have no ...
Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced the Company has secured multiple market access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results